Idexx Laboratories (IDXX) Cash from Investing Activities (2009 - 2026)

Idexx Laboratories' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$33.5 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 13.29% year-over-year to -$33.5 million; the TTM figure through Mar 2026 stood at -$140.2 million (down 8.05% YoY), while the FY2025 annual figure was -$136.2 million, up 34.2% from the prior year.
• Cash from Investing Activities was -$33.5 million for Q1 2026 at Idexx Laboratories, down from -$28.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$27.4 million in Q3 2024 to a low of -$106.9 million in Q1 2024.
• Historically, Cash from Investing Activities has averaged -$41.0 million across 5 years, with a median of -$33.6 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities tumbled 170.67% in 2024, then soared 72.31% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$49.2 million in 2022, then surged by 38.18% to -$30.4 million in 2023, then tumbled by 30.91% to -$39.8 million in 2024, then climbed by 29.4% to -$28.1 million in 2025, then dropped by 19.25% to -$33.5 million in 2026.
• The last three Cash from Investing Activities figures came in at -$33.5 million (Q1 2026), -$28.1 million (Q4 2025), and -$44.9 million (Q3 2025), per Business Quant data.